Lower expression levels of the transforming growth factor beta receptor type II protein are associated with a less aggressive tumor phenotype and improved survival among patients with clear cell renal cell carcinoma

Alexander Scott Parker, Christine M. Lohse, Kevin Wu, Pamela Kreinest, John A. Copland, Tracy Hilton, Michael Wehle, John C. Cheville, Michael Blute

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Lower expression levels of the transforming growth factor beta receptor type II protein are associated with a less aggressive tumor phenotype and improved survival among patients with clear cell renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences